Mechanisms underlying the development of androgen-independent prostate cancer

被引：355
作者：
Pienta, KJ [1 ]
Bradley, D [1 ]
机构：
[1] Univ Michigan, Michigan Urol Ctr, Ann Arbor, MI 48109 USA
来源：
CLINICAL CANCER RESEARCH | 2006年 / 12卷 / 06期
关键词：
D O I：
10.1158/1078-0432.CCR-06-0067
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1665 / 1671
页数：7
相关论文
共 95 条
[1]   Role of tyrosine kinase inhibitors in cancer therapy [J].
Arora, A ;
Scholar, EM .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (03) :971-979
[2]   Phase I trial of 177lutetium-labeled J591, a monoclonal antibody to prostate-specific membrane antigen, in patients with androgen-independent prostate cancer [J].
Bander, NH ;
Milowsky, MI ;
Nanus, DM ;
Kostakoglu, L ;
Vallabhajosula, S ;
Goldsmith, SJ .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (21) :4591-4601
[3]   Phase I pharmacokinetic and pharmacodynarnic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies [J].
Banerji, U ;
O'Donnell, A ;
Scurr, M ;
Pacey, S ;
Stapleton, S ;
Asad, Y ;
Simmons, L ;
Maloney, A ;
Raynaud, F ;
Campbell, M ;
Walton, M ;
Lakhani, S ;
Kaye, S ;
Workman, P ;
Judson, I .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (18) :4152-4161
[4]   Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer [J].
Beer, TM ;
Eilers, KM ;
Garzotto, M ;
Egorin, MJ ;
Lowe, BA ;
Henner, WD .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) :123-128
[5]   Metastatic patterns of prostate cancer:: An autopsy study of 1,589 patients [J].
Bubendorf, L ;
Schöpfer, A ;
Wagner, U ;
Sauter, G ;
Moch, H ;
Willi, N ;
Gasser, TC ;
Mihatsch, MJ .
HUMAN PATHOLOGY, 2000, 31 (05) :578-583
[6]  
Buchanan G, 2001, CLIN CANCER RES, V7, P1273
[7]   Immunotherapy (APC8015, Provenge®) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer:: A phase 2 trial [J].
Burch, PA ;
Croghan, GA ;
Gastineau, DA ;
Jones, LA ;
Kaur, JS ;
Kylstra, JW ;
Richardson, RL ;
Valone, FH ;
Vuk-Pavlovic, S .
PROSTATE, 2004, 60 (03) :197-204
[8]  
Butler LM, 2000, CANCER RES, V60, P5165
[9]   Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer [J].
Chan, S .
BRITISH JOURNAL OF CANCER, 2004, 91 (08) :1420-1424
[10]   Development of peptide antagonists for the androgen receptor using combinatorial peptide phage display [J].
Chang, CY ;
Abdo, J ;
Hartney, T ;
McDonnell, DP .
MOLECULAR ENDOCRINOLOGY, 2005, 19 (10) :2478-2490
12345678910